Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 19.11.2025Viatris Healthcare Limited (VIM-1)49450Gopten 0,5 mg (cps 20x0,5 mg (blis.PVC/PVDC/Al))21.11.2025R
 19.11.2025H. Lundbeck A/S (LUN-2)88480Cisordinol 10 mg (tbl flm 50x10 mg (obal HDPE))19.11.2025R
 19.11.2025TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)13444Abelcet lipid complex (dis inf 10x20 ml (liek.inj.skl.))19.11.2025Z
 19.11.2025Recordati Industria Chimica e Farmaceutica S.p.A. (REC-1)83974Betaloc 1 mg/1 ml (sol inj 5x5 ml (amp.skl.))19.11.2025R
 18.11.2025Almirall Hermal GmbH (POS-D)60405Balneum Hermal (add bal 1x500 ml (fľ.PVC))18.11.2025R
 18.11.2025Almirall Hermal GmbH (POS-D)60413Balneum Hermal Plus (add bal 1x500 ml (fľ.PVC))18.11.2025R
 18.11.2025TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)5784BNASAL DUO ACTIVE 0,5/50 mg/ml (aer nao 1x10 ml/90 dávok (fľ.HDPE s mech.rozpraš.))18.11.2025R
 18.11.2025Teva B.V. (TEV-NL-4)76402Sorbimon 20 mg (tbl 100x20 mg)18.11.2025R
 18.11.2025Teva B.V. (TEV-NL-4)47861Myfenax 500 mg filmom obalené tablety (tbl flm 50x500 mg (blis.PVC/PVDC/Al))18.11.2025R
 18.11.2025B.Braun Melsungen AG (BME)33833Hydrogenuhličitan sodný B. Braun 4,2 % (sol inf 10x250 ml (fľ.skl.))18.11.2025R
 18.11.2025B.Braun Melsungen AG (BME)80181Gentamicin B. Braun 3 mg/ml infúzny roztok (sol inf 20x80 ml/240 mg (fľ. LDPE))18.11.2025R
 17.11.2025Gedeon Richter Plc. (GDN)31552Ossica 3 mg injekčný roztok naplnený v injekčnej striekačke (sol iru 1x3 ml/3 mg (striek.inj.napln.) + 1x inj.ihla)25.11.2025R
 17.11.2025STADA Arzneimittel AG (STD)4789EMetformin STADA 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/Al))12.11.2025U
 17.11.2025Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)8419AAbilify Maintena 400 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x400 mg+1x2 ml+samost.bal.(liek.inj.skl.))17.11.2025O
 17.11.2025Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)4771BAbilify Maintena 400 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním v naplnenej injekčnej striekačke (plu igf 1x400 mg+1x1,6 ml (striek.inj.skl.napl.))17.11.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)